Related Content
Why affordable provider-administered drugs for all Tennesseans must be a priority
Natalie Tate | Jan 12, 2022
Responding to Continued Misleading Claims by the Coalition of State Rheumatology Organizations
Roy Vaughn | Jun 23, 2020
Moving forward with flexibility: Q&A on our specialty pharmacy changes
John Hawbaker | May 28, 2020
Setting the Record Straight about our Specialty Drug Program
Scott Neal Wilson | Feb 13, 2020
Response to Misleading Claims by the Coalition of State Rheumatology Organizations about our Specialty Pharmacy Program
Roy Vaughn | Jan 31, 2020
7 key facts about our specialty pharmacy changes
Natalie Tate | Jan 8, 2020